Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ENDRA Life Sciences (NDRA) Operating Expenses (2016 - 2025)

ENDRA Life Sciences has reported Operating Expenses over the past 6 years, most recently at $3.1 million for Q4 2021.

  • Quarterly Operating Expenses rose 36.25% to $3.1 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $11.5 million through Dec 2021, changed 0.03% year-over-year, with the annual reading at $5.8 million for FY2025, 46.72% down from the prior year.
  • Operating Expenses was $3.1 million for Q4 2021 at ENDRA Life Sciences, up from $2.7 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $3.3 million in Q3 2020 and troughed at $360697.0 in Q1 2017.
  • The 5-year median for Operating Expenses is $2.6 million (2019), against an average of $2.4 million.
  • Year-over-year, Operating Expenses soared 688.42% in 2018 and then fell 27.99% in 2020.
  • A 5-year view of Operating Expenses shows it stood at $2.3 million in 2017, then decreased by 12.93% to $2.0 million in 2018, then soared by 56.31% to $3.1 million in 2019, then fell by 27.99% to $2.3 million in 2020, then surged by 36.25% to $3.1 million in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Operating Expenses are $3.1 million (Q4 2021), $2.7 million (Q3 2021), and $3.2 million (Q2 2021).